Clinical trial
The New Strategy for Pharmacological Treatment in People With Schizophrenia
NCT00352339 · Inje University, Other · Unknown status
Key facts
| NCT number | NCT00352339 |
|---|---|
| Title | The New Strategy for Pharmacological Treatment in People With Schizophrenia |
| Official title | Switch Risperidone to Aripiprazole in Early Stage of Pharmacotherapy of Schizophrenia |
| Lead sponsor | Inje University, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Rispridoen and Aripiprazole, Risperidne, Abilify |
| Enrollment | 90 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jul 14, 2006 |
| Last update posted | Aug 6, 2009 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: